lung cancer | |||||
新闻 | |||||
Roche newcomer Tecentriq has Bristol's Opdivo bleeding lung cancer share: execs Bristol-Myers Squibb has run up against some serious issues trying to expand Opdivo's reach in lung cancer. In the meantime, rivals are poaching ...
| |||||
SLU Researcher Unlocks Mystery of 'Chemo-Brain', Identifies Possible Treatment LOUIS — Though chemotherapy can be lifesaving, the cancer treatment often ... testicular, colon, breast, ovarian and non-small cell lung cancers.
| |||||
bioAffinity Technologies Announces Pricing of IPO | Business | valdostadailytimes.com ... net proceeds for the commercialization of its diagnostic called CyPath ® Lung, a non-invasive test for the early detection of lung cancer that ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment